Institutions Holding Call Options on Arcus Biosciences, Inc. (RCUS)
This table provides information about the call option holders of Arcus Biosciences, Inc. (RCUS). We have compiled data on the institutions that hold call options on the stock, with a total of 3.18 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $30.8 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Balyasny Asset Management LLC
Chicago, IL |
Aug 14, 2025 Q2 2025 |
1,707,500
calls
|
$16.5 Million
0.02% of portfolio
|
Q2 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1,265,900
calls
|
$12.2 Million
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
83,500
calls
|
$807,445
0.0% of portfolio
|
N/A
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
76,000
calls
|
$734,920
0.0% of portfolio
|
N/A
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
29,800
calls
|
$288,166
0.0% of portfolio
|
N/A
|
|
|
Nomura Holdings Inc
Tokyo, M0 |
Aug 14, 2025 Q2 2025 |
21,100
calls
|
$204,037
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Walleye Capital LLC
Plymouth, MN |
Aug 13, 2025 Q2 2025 |
100
calls
|
$967
0.0% of portfolio
|
Q2 2025
New holding
|